What are the indications for dobutamine stress echocardiography in patients undergoing non‑cardiac surgery?

Dobutamine Stress Echo Indications in Non-Cardiac Surgery

Dobutamine stress echocardiography is reasonable for patients at elevated cardiovascular risk undergoing elevated-risk non-cardiac surgery who have poor functional capacity (<4 METs) and in whom the results will change perioperative management. 1, 2

Patient Selection Algorithm

Dobutamine stress echo should be considered when ALL of the following criteria are met:

• Elevated surgical risk procedure (not low-risk surgery like cataract, breast, or ambulatory procedures)
• Poor or unknown functional capacity (<4 METs - unable to climb 2 flights of stairs or walk 4 blocks)
• Elevated cardiovascular risk (≥1 on Revised Cardiac Risk Index)
• Test results will alter management (e.g., guide medical optimization, inform surgical decision-making, or change perioperative monitoring strategy)

1, 2

When NOT to Perform Dobutamine Stress Echo

Absolute Contraindications:

• Critical or hemodynamically significant aortic stenosis
• Hemodynamically significant left ventricular outflow tract obstruction
• Acute coronary syndrome
• Decompensated heart failure
• Uncontrolled arrhythmias
• Severe systemic hypertension (≥200/110 mmHg)
• Acute aortic dissection
• Pericarditis/myocarditis
• Pulmonary embolism
• Severe pulmonary hypertension

1

Clinical Scenarios Where Testing is NOT Useful:

• Low-risk surgery - routine screening provides no benefit and delays surgery 1, 2
• Low-risk patients (RCRI = 0) - even with risk factors or suspected CAD, testing is not cost-effective and does not improve outcomes 1
• Stable patients with good functional capacity (≥4 METs) - exercise capacity alone provides adequate risk stratification 2

Test Performance Characteristics

The evidence demonstrates dobutamine stress echo has:

• Negative predictive value: >90-96% - a normal test effectively rules out perioperative cardiac events 1, 3, 4, 5
• Positive predictive value: 0-43% depending on population and ischemic threshold 1, 5
• Sensitivity: 100% in some studies for perioperative events 3, 5
• Specificity: 63% 5

The highest risk patients are those with ischemia occurring at <60% of age-predicted maximal heart rate, who have a 43% event rate compared to 0% in those without ischemia 5.

Key Clinical Pearls

Exercise testing is always preferred over pharmacological stress when the patient can exercise - dobutamine stress echo is specifically for patients unable to perform adequate exercise testing 1, 2.

The choice between dobutamine stress echo versus pharmacological myocardial perfusion imaging should be based on local expertise, as no randomized trials demonstrate superiority of one modality over another 2. A meta-analysis suggested slight superiority of stress echocardiography, but this should not override institutional experience 2.

Common Pitfalls to Avoid

1. Over-testing low-risk scenarios - The most common error is ordering stress testing in patients undergoing low-risk surgery or in stable patients with good functional capacity, which is costly, delays surgery, and does not improve outcomes 1

2. Testing when results won't change management - If you plan to proceed with surgery regardless of results, or if the patient is already optimally medically managed, testing adds no value 2

3. Ignoring contraindications - Particularly critical aortic stenosis and LVOT obstruction, which can lead to hemodynamic collapse with dobutamine 1

4. Misinterpreting fixed defects - Old myocardial infarction on imaging does not predict perioperative MI or cardiac death, though it has longer-term prognostic implications 1